Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT01465256
Eligibility Criteria:
Inclusion Criteria:
* The patients who take low dose aspirin (75\~160mg) for primary prevention of vascular disease and low risk for thromboembolism.
Exclusion Criteria:
* The patients who taking anti-thrombotic agents,
* The patients who taking thienopyridines or other NSAID with aspirin,
* The patients who have low platelet count(\<80,000/mm3) and prolongated PT/aPTT in laboratory test,
* The patients who have chronic renal disease (creatinine\>3mg/dl over 6 months),
* The patients who have polyps over than 1 cm in size or thick pedicle over 1 cm,
* The patients who have GI malignancies,the patients who are over ASA classification class III.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT01465256
Study Brief:
Protocol Section:
NCT01465256